Nanoliposomal irinotecan and fluorouracil plus leucovorin versus fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies (AIO NALIRICC): a multicentre, open-label, randomised, phase 2 trial - Vogel, Arndt; Saborowski, Anna; Wenzel, Patrick; Wege, Henning; Folprecht, Gunnar; Kretzschmar, Albrecht; Schütt, Philipp; Jacobasch, Lutz; Ziegenhagen, Nicolas; Boeck, Stefan; Zhang, Danmei; Kanzler, Stephan; et al. (The lancet. Gastroenterology & Hepatology, 2024)
Online veröffentlicht: 10. Juni 2024, Artikelversion: 3. Juli 2024